Immunome (IMNM) Shares Outstanding (Diluted Average) (2023 - 2025)
Historic Shares Outstanding (Diluted Average) for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $88.0 million.
- Immunome's Shares Outstanding (Diluted Average) rose 4609.65% to $88.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.0 million, marking a year-over-year increase of 4609.65%. This contributed to the annual value of $58.6 million for FY2024, which is 19550.73% up from last year.
- Immunome's Shares Outstanding (Diluted Average) amounted to $88.0 million in Q3 2025, which was up 4609.65% from $87.0 million recorded in Q2 2025.
- In the past 5 years, Immunome's Shares Outstanding (Diluted Average) registered a high of $88.0 million during Q3 2025, and its lowest value of $12.2 million during Q1 2023.
- Its 3-year average for Shares Outstanding (Diluted Average) is $49.2 million, with a median of $58.6 million in 2024.
- Per our database at Business Quant, Immunome's Shares Outstanding (Diluted Average) skyrocketed by 39339.19% in 2024 and then skyrocketed by 4517.11% in 2025.
- Quarter analysis of 3 years shows Immunome's Shares Outstanding (Diluted Average) stood at $19.8 million in 2023, then skyrocketed by 195.51% to $58.6 million in 2024, then surged by 50.0% to $88.0 million in 2025.
- Its Shares Outstanding (Diluted Average) stands at $88.0 million for Q3 2025, versus $87.0 million for Q2 2025 and $79.4 million for Q1 2025.